跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SCALPICIN ANTI-DANDRUFF ANTI-ITCH LIQUID - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SCALPICIN ANTI-DANDRUFF ANTI-ITCH LIQUID
Authorized
STANDARD
SCALPICIN ANTI-DANDRUFF ANTI-ITCH LIQUID
COMBE INCORPORATED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5557737ee3ebafbc
Company
COMBE INCORPORATED
Type
Standard
Approval Details
Approval Id
5557737ee3ebafbc
Drug Approval Canada Name
SCALPICIN ANTI-DANDRUFF ANTI-ITCH LIQUID
Product Name
SCALPICIN ANTI-DANDRUFF ANTI-ITCH LIQUID
Status
Cancelled Post Market
Status Date
1999-07-14
Original Market Date
1994-12-31
Din
02102757
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:28.00
Atc Original
D11AC30 OTHERS
Atc Name
d 11 ac 30
Aig Number
0226276001
Company Name
COMBE INCORPORATED
Company Address
1101 Westchester Avenue, White Plains, New York, United States, 10604-3597
Company Detail Path
/organization/combe-incorporated
Company Information
Pharmaceutical Company Name
COMBE INCORPORATED
Country Name
United States
Province Name
Washington
City Name
lynnwood,washington,country_us
Address
19020 33RD Ave W Ste 240
Active Ingredients
MENTHOL
.1 %
SALICYLIC ACID
1.8 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5557737ee3ebafbc
Type
Standard
Back to Health Canada Approvals